
Douglas Wood, M.D., F.A.C.S., F.R.C.S.Ed., is a board certified surgeon at UW Medical Center’s Thoracic Surgery Clinic and the UW’s Henry N. Harkins Professor and Chair of Surgery. Dr. Wood is world-renowned in thoracic oncology, particularly lung and esophageal cancer. He is also a national and international leader in the management of complex airway disease and in the surgical management of end-stage lung disease. He has led the UW Thoracic Group to be the leading referral center for patients from all over the Pacific Northwest. Dr. Wood earned his M.D. from Harvard. He is board certified in both Surgery and Thoracic Surgery. Dr. Wood has had a major role in leadership and policy in surgery and thoracic oncology nationally and internationally. He has leadership roles in many medical organizations and has been a visiting professor at over 50 institutions worldwide.
Selected publications from PubMed
Are We Still "Choosing Wisely" in Thoracic Surgery?
Mott NM, Fendrick AM, Ragavan MV, Wood DE, Meguid RA
Ann Thorac Surg. 2026 Jul 17 pii: S0003-4975(26)00721-6. doi: 10.1016/j.athoracsur.2026.06.064.
The American Cancer Society National Lung Cancer Roundtable strategic plan: Addressing planning for lung cancer interventions at the state and local level through the creation of the National Lung Cancer Roundtable Planning Tool.
Olson JMG, Knight JR, Copeland AM, Ohlander KA, Bathje KH, Burson HC, Domingo CA, Durden KA, Dickson-Gavney E, Hofmann KE, Mullett TW, Rosenthal LS, Kazerooni EA, Wood DE, Smith RA
Cancer. 2025 Aug 15;131(16):e35954 doi: 10.1002/cncr.35954.
From Enigma to Equity: Asian American and Pacific Islanders in Cardiothoracic Surgery.
Lesgart M, Nguyen AA, Tompkins AK, Berfield KS, Kim R, Wood DE, Cooke DT, Erkmen CP, Society of Thoracic Surgeons Workforce on Diversity, Equity, and Inclusion
Ann Thorac Surg. 2025 Jul;120(1):150-156 doi: 10.1016/j.athoracsur.2025.01.036.
Gender representation in cardiothoracic surgical academia: A call to support women across the globe.
Pompili C, Costa R, Cangut B, Opitz I, Figueroa PU, Molena D, Backhus L, Blackmon S, Fiedler A, Kluin J, Cleuziou J, Melfi F, Fuller S, Wood DE, Antonoff MB
J Thorac Cardiovasc Surg. 2025 Mar;169(3):685-690.e1 doi: 10.1016/j.jtcvs.2024.09.032.
Gender Representation in Cardiothoracic Surgical Academia: A Call to Support Women Across the Globe.
Pompili C, Costa R, Cangut B, Opitz I, Figueroa PU, Molena D, Backhus L, Blackmon S, Fiedler A, Kluin J, Cleuziou J, Melfi F, Fuller S, Wood DE, Antonoff MB
Ann Thorac Surg. 2025 Feb;119(2):274-279 doi: 10.1016/j.athoracsur.2024.10.012.

Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we are proud to introduce Meet the Masters, as part of the Healing in China series, which brings together the best Chinese KOLs and top surgeons from other regions of the world to guide you through their surgeries and transfer years of knowledge. In this event, AIS Channel specially invites top thoracic surgery experts from China, the United Kingdom and the United States to share academic insights on lobectomy after neoadjuvant therapy. This event features operation videos, case sharing, and interactive discussions to enhance surgical skills and improve global standards in this field.
With Johnson & Johnson MedTech
Published
Jun 2023

As cataclysmic events have demonstrated the pressing need to provide diversity, equity, and inclusion in all walks of life, professional organizations have responded with programs and other interventions to ensure these concepts are included in our clinical care, membership and leadership of professional organizations, with particular attention to our pipeline of future membership. In light of this, Specialty Surgery Regents from the American College of Surgeons have come together in this program to share the efforts made in their academic programs and professional societies to address their diverse needs and concerns. Each specialty is unique in the demographics of its patients and surgical workforce. Each has different priorities and solutions. The panelists share their collective experiences, programs, and initiatives in an effort to provide innovative solutions to all surgeons and surgical organizations. The program is constructed to inspire others in their efforts to bring Diversity, Equity, and Inclusion to all aspects of surgical life and surgical care and provide a bright future for ALL of our patients and surgeons.
With Johnson & Johnson MedTech
Published
Sep 2022

Cardiothoracic surgery is among the least diverse specialties in terms of racial and gender diversity. Lack of diversity is detrimental to patient care, physician well-being, and stifles innovation.
With Medtronic
Published
Nov 2021

Welcome and introduction – Dr. Douglas Wood (USA) and Dr. Steven D. Wexner (USA) Time for a change: women leading in cardiothoracic surgery – Dr. Leah Backhus (USA) The National and Global impact of “Women in Thoracic Surgery” – Dr. Lauren C. Kane (USA) Women in thoracic surgery: European perspectives – Dr. Cecilia Pompili (UK) Realities and challenges for female cardiothoracic surgeons: an African perspective – Dr. Susan Vosloo (South Africa) Women in thoracic surgery: Asian perspective – Dr. Aki K Kobayashi (Japan) Women in thoracic surgery: perspectives from South America – Dr. Paula Ugalde (Brazil) From female surgical resident to academic leaders: challenges and pathways forward – Dr. Gunda Leschber (Germany) Discussion – All faculty moderated by Dr. Douglas Wood (USA)
With Medtronic
Published
Oct 2021

PROGRAM Creating a DE&I culture in a health care enterprise – Dr. Conor Delaney (USA)Prioritizing DE&I at the American College of Surgeons – Dr. Timothy Eberlein (USA)Conquering unconscious bias – Dr. Doug Wood (USA)Developing women leaders – Dr. Diana Farmer (USA)Disparities in cancer care – Dr. William Cance (USA)Diversity in Clinical Trials – Ms. Cassandra Smith (USA)Discussion –All faculty moderated by Dr. Steven Wexner (USA) and Dr. Patricia Turner (USA) FACULTY Dr William Cance (USA) – Chief Medical and Scientific Officer of the American Cancer Society Dr Conor Delaney (USA) – CEO of Cleveland Clinic Florida, USA Dr Timothy Eberlein (USA) – Director, Alvin J. Siteman Cancer Center, Spencer T. and Ann W. Olin Distinguished Professor; and Bixby Professor and Chairman, Department of Surgery, Washington University School of Medicine, USA Dr Diana Farmer (USA) – Chair of Surgery at the University of California Davis Health System; American College of Surgeons Board of Regents Ms. Cassandra Smith - Director, Diversity & Inclusion in Clinical Trials at The Janssen Pharmaceutical Companies of Johnson & Johnson Dr Patricia Turner (USA) – Director, Division of Membership Services, American College of Surgeons past Chair, AMA Council on Medical Education; past Chair, Surgical Section, National Medical Association; past President, Society of Black Academic Surgeons; and Member, Board of Directors, Council on Medical Specialty Societies Dr Steven Wexner (USA) – Director, Digestive Disease Institute, Chair, Department of Colorectal Surgery, Cleveland Clinic Florida, Past President American Society of Colon and Rectal Surgeons, Past President American Board of Colon and Rectal Surgery, Past President Society of American Gastrointestinal and Endoscopic Surgeons, Editor-in-Chief Surgery, Vice-Chair, Board of Regents, American College of Surgeons Dr Doug Wood (USA) – The Henry N. Harkins Professor and Chair, Department of Surgery, University of Washington; American College of Surgeons Board of Regents; Past President of the Society of Thoracic Surgeons; Past Director of the American Board of Thoracic Surgery; Past President Cardiothoracic Surgery Network (CTSNet)
Published
Jul 2021
Help your network discover Dr. Douglas E Wood's clinical expertise.